Trials / Completed
CompletedNCT06207396
Characteristics of Spiking in Ghent: a Multicentric Prospective Observational Study..
Characteristics of Spiking in Ghent: A Multicentric Prospective Observational Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 107 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study aims to document the incidence and characteristics of spiking in the Ghent region, both anamnestically and by toxicological analysis. Spiking will be analyzed by immunoassay testing and high-resolution screening according to the protocol in the laboratory of UZ Gent;
Detailed description
This study aims at objectivating and characterizing the patients with alleged spiking in the city of Ghent. Every patient who presents at one of the four (out of four) emergency departments of Ghent, with a suspicion of spiking (drink/food/needle-spiking included), will be offered to take part of this study. The study entails a list of questions for the patient regarding demographics, recent own medication/drug/alcohol use and experienced symptoms; whilst the caregiver (doctor/nurse) completes a questionnaire regarding symptoms at time of presentation. For a presentation within 48h after event, both blood and urine samples are requested from the patient. When presenting between 48h and 96h after the event, only urine samples are requested. On this samples, IA and LC-GCMS according to the UNODOC standards ("Guidelines for the Forensic analysis of drugs facilitating sexual assault and other criminal acts") to objectify exogenous products. On request of the patient, these results can be added to the medical file of the patient.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | serum and urine analysis | Spiking will be analyzed by immunoassay testing and high-resolution screening |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2025-03-31
- Completion
- 2025-05-31
- First posted
- 2024-01-17
- Last updated
- 2026-01-07
Locations
4 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT06207396. Inclusion in this directory is not an endorsement.